Clinical Trial Update: Intramuscular Aripiprazole in Acutely Agitated Patients Diagnosed With Dementia [Phase 3]

View source ↗

Summary

Phase 3 trial of intramuscular aripiprazole for acute agitation in dementia patients (including Alzheimer's disease) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Dementia

Drugs mentioned

• Abilify (aripiprazole)

Snippet

Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. | Conditions: Dementia, Alzheimer's Disease | Phase 3 | Status: COMPLETED